• Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer

  • Sep 30 2024
  • Length: 12 mins
  • Podcast

Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer

  • Summary

  • Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer.

    Related Content:

    • Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing
    • Screening for Helicobacter pylori to Prevent Gastric Cancer
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.